Want to join the conversation?
Specialty pharmaceutical company $AGN posted 4Q15 net loss of $700.5MM or $2.13 loss per share vs. $732.9MM or $2.75 loss per share in 4Q14. Non-GAAP diluted EPS from continuing operations was $3.41. Net revenues from continuing operations rose 74% to $4.2Bil, helped by increased revenue in US, Medical Aesthetics, International and Anda brands.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?